Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis.
Vertex Pharmaceuticals stock last closed at $477.52, down 2.37% from the previous day, and has increased 19.4% in one year. It has overperformed other stocks in the Biotechnology industry by 0.97 percentage points. Vertex Pharmaceuticals stock is currently +26.38% from its 52-week low of $377.85, and -8.15% from its 52-week high of $519.88.
At the moment, there are 256.79M shares of VRTX outstanding. The market cap of VRTX is $122.62B. In the last 24 hours, 1.12M VRTX shares were traded.
How to Buy Vertex Pharmaceuticals Stock
Not sure how to invest in Vertex Pharmaceuticals stock? Here's how.
Decide where to buy Vertex Pharmaceuticals stock: You need to choose a stock brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you determine where to buy Vertex Pharmaceuticals stock.
Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
Put funds into your brokerage account: Pick your method of payment and add your details.
Research Vertex Pharmaceuticals stock: The Vertex Pharmaceuticals ticker symbol is VRTX. Is Vertex Pharmaceuticals stock a good investment? Should you buy shares of VRTX? How do VRTX's underlying business fundamentals look? Do top analysts think Vertex Pharmaceuticals is a good buy? Why has VRTX's stock price moved recently? (Hint: Our stock market analysis website can help you evaluate if VRTX is a good stock to buy).
Execute your VRTX purchase: Decide if you will purchase VRTX shares at the current market price or use a limit order to purchase VRTX shares at a particular price.
Get the latest scoop on your investment in VRTX: Create a watchlist to important notifications about your investment in Vertex Pharmaceuticals shares.
Step 1: Decide where to buy Vertex Pharmaceuticals stock
You will need a brokerage account in order to access the NASDAQ market and buy VRTX shares.
A brokerage account is an investment account that allows you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
We believe that eToro is the best stock brokerage. eToro gives you:
Invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
Access to global financial markets: From Technology to Real Estate, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've picked the right brokerage, you'll need to fill out some personal info so you are able to invest in VRTX stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Vertex Pharmaceuticals stock
After you have identified the best place to buy Vertex Pharmaceuticals stock, it's important to analyze their stock prior to investing, so you actually understand the risk as well as the opportunity.
Vertex Pharmaceuticals quick stats
VRTX Price
$477.52
1w %
-3.69%
1y %
19.4%
5y %
81.7%
P/E
-229.58x
P/B
7.47x
P/S
11.18x
PEG
N/A
Revenue
$11.02B
Earnings
-$535.60M
Fore. Rev. Growth
8.4%
Fore. Earn. Growth
N/A
Market Cap
$122.62B
Next Earnings
May 5, 2025
Next Dividend
N/A
Vertex Pharmaceuticals Due Diligence Score
WallStreetZen was designed to help everyday investors do better fundamental analysis.
VRTX has cash burn of 790300000. It has sufficient cash and short-term investments to cover this for at least one year.
VRTX has $6.12B in cash and short term investments. This is sufficient to cover its annual cash burn of $790.30M.
There are more short-term assets than long-term liabilities on the VRTX balance sheet.
There are more short-term assets than short-term liabilities on the VRTX balance sheet.
VRTX has a low debt to equity ratio of 0.37.
Cons:
Total VRTX debt is higher than 5 years ago, relative to shareholder equity.
VRTX profit margin has gone down from 36.7% to -4.9% in the past year.
Is it a good time to buy Vertex Pharmaceuticals stock, according to Wall Street analysts?
Out of 18 sell side analysts who give ratings on VRTX, the consensus analyst rating on Vertex Pharmaceuticals is a Buy
Please note that analyst ratings are not stock recommendations, nor are they financial advice.
Latest VRTX Analyst Recommendations
Olivia Brayer, a top 32% analyst from Cantor Fitzgerald reiterates VRTX with a strong buy rating and maintains their VRTX price target from $480.00 to $480.00, on Feb 11, 2025.
Gena Wang, a bottom 5% analyst from Barclays maintains VRTX with a hold rating and raises their VRTX price target from $435.00 to $467.00, on Feb 11, 2025.
Andrew Fein, a bottom 2% analyst from HC Wainwright & Co. reiterates VRTX with a buy rating and maintains their VRTX price target from $550.00 to $550.00, on Feb 11, 2025.
Matthew Harrison, a bottom 21% analyst from Morgan Stanley maintains VRTX with a hold rating and raises their VRTX price target from $450.00 to $459.00, on Feb 11, 2025.
Mohit Bansal, a top 13% analyst from Wells Fargo downgrades VRTX to a hold rating and maintains their VRTX price target from $460.00 to $460.00, on Jan 30, 2025.
Last year, VRTX revenue was $11.02B. Over the past five year, VRTX's revenue has increased by 21.5% per year. This was slower than the Biotechnology industry average of 44.31%.
In the past 12 months, insiders at VRTX have sold more shares than they have bought.
David Altshuler, EVP Chief Scientific Officer of VRTX, was the latest VRTX insider to sell. They sold $1,647,810.00 worth of VRTX shares on Mar 13, 2025.
No, Vertex Pharmaceuticals doesn't provide an income stream by paying out dividends.
VRTX Social Trading Data
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Execute your VRTX purchase
There are two main order types:
Market order: A market order is an order to buy or sell a stock at the best price on the market. Market orders are generally the easiest way to buy.
Limit order: A limit order enables you to buy or sell a security at a specific price (or better). If you want to be certain you're buying or selling at a given dollar amount limit, place a limit order.
Hit the Open button and eToro will place the order.
If you require more assistance investing in stocks on eToro, click the helpful video below:
How much does it cost to buy one Vertex Pharmaceuticals share?
As of Apr 21, 2025, it costs $477.52 to buy one share of Vertex Pharmaceuticals stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $100, you can buy 0.209 shares of VRTX.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.